Editorial: The management of hematologic malignancies in lower-income countries

Ganesan, Prasanth; Cheikh, Jean El; Isidori, Alessandro; Kuo, Sung‐Hsin; Saleh, Mustafa; Nair, Reena

doi:10.3389/fonc.2023.1218718

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Its population is estimated at around 360 million people. [ 7 , 8 ] While BC is mostly prevalent in Northern America and Europe, countries like Syria and Egypt record comparable age-standardized incidence rates (ASR). [ 9 ] Lebanon holds one of the highest ASRs in males among the world population for BC, with a rate of 34.0, surpassing other countries that have previously been identified as having high ASR values, such as Belgium and its neighboring nation, Egypt, which have ASR values of 32.0 and 26.3, respectively.…”

Section: Introductionmentioning

confidence: 99%

Arab world’s impact on bladder cancer research and opportunities for growth: A bibliometric review study

Saleh,

Raffoul,

Akil

et al. 2024

Medicine

Self Cite

View full text Add to dashboard Cite

Background: Bladder Cancer (BC) is a widespread form of cancer that affects over 1.6 million people globally. The majority of cases are diagnosed as urothelial carcinoma, with a higher likelihood of diagnosis in men and with increasing age. The Arab world (AW) is one of the regions with the highest incidence and mortality rates of BC, and the average age of diagnosis is between 40 and 49 years in North Africa and the Middle East. This study aims to assess the activity and distribution of BC publications in the AW. Methods: A systematic search across MEDLINE and Embase databases spanning 2007 to 2021 identified 1208 English-language articles on bladder cancer with Arab affiliations. The dataset was normalized against the average population and GDP (2007–2020) for 22 Arab countries. Statistical analyses via SPSS and visualizations with VOSviewer unveiled collaboration patterns and thematic trends in Arab bladder cancer research. Results: A total of 1208 BC publications were published in the AW, representing 0.24% of all biomedical publications. Egypt topped the list with the highest number of publications. The co-authorship analysis generated by VOSviewer revealed that out of 4766 authors, 161 met the minimum threshold of 5 publications. Conclusion: The findings reveal that Egypt and Jordan are at the forefront of BC research in the region, while other Arab countries are lagging behind despite being heavily impacted by the disease. To drive progress in the field, it’s important to uncover the obstacles impeding BC research in these countries and implement effective solutions to overcome them.

show abstract

Section: Introductionmentioning

confidence: 99%